Coya Therapeutics reported earnings of -$ 0.45 per COYA share on Nov 10, 2026, beating analysts' expectations by
| Report Date | Nov 10, 2026 |
|---|---|
| Forecasted EPS | -$ 0.34 |
| Earnings Per Share (Surprise) | -$ 0.45 (-$ 0.11) |
| Last Year's EPS | -$ 0.31 |
| EPS YoY Change |
Out of the last 23 earnings reporting periods, Coya Therapeutics beat analysts’ expectations 7 times and fell short of expectations 7 time(s). Coya Therapeutics reported earnings per share of -$ 0.45 in the last report falling to reach an estimated EPS of -$ 0.34 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 10, 2026 | -$ 0.34 | -$ 0.45 | -$ 0.10 | |
| Aug 11, 2026 | -$ 0.35 | -$ 0.28 | -$ 0.36 | |
| May 12, 2026 | -$ 0.39 | -$ 0.32 | -$ 0.44 | |
| Mar 16, 2026 | -$ 0.27 | -$ 0.34 | -$ 0.18 | |
| Nov 12, 2025 | $ 0.02 | -$ 0.10 | -$ 0.26 | |
| Aug 12, 2025 | -$ 0.22 | -$ 0.36 | -$ 0.19 | |
| May 13, 2025 | -$ 0.44 | -$ 0.44 | -$ 0.35 | |
| Mar 18, 2025 | -$ 0.26 | -$ 0.18 | $ 0.15 | |
| Nov 6, 2024 | -$ 0.41 | -$ 0.26 | -$ 0.34 | |
| Aug 12, 2024 | -$ 0.14 | -$ 0.19 | -$ 0.31 | |
| May 9, 2024 | -$ 0.30 | -$ 0.35 | -$ 0.28 | |
| Mar 19, 2024 | $ 0.26 | $ 0.15 | -$ 0.24 | |
| Nov 8, 2023 | -$ 0.37 | -$ 0.34 | -$ 0.52 | |
| Aug 8, 2023 | -$ 0.32 | -$ 0.31 | -$ 0.42 | |
| May 10, 2023 | -$ 0.43 | -$ 0.28 | -$ 0.26 | |
| Mar 29, 2023 | - | -$ 0.24 | -$ 0.25 | |
| Dec 30, 2022 | - | -$ 0.52 | -$ 0.14 | |
| Sep 30, 2022 | - | -$ 0.42 | -$ 0.37 | |
| Mar 31, 2022 | - | -$ 0.26 | -$ 0.37 | |
| Dec 31, 2021 | - | -$ 0.25 | - | - |
Coya Therapeutics’s stock was trading at $ 3.33 on Nov 9, 2026 a day before the last earnings report was released.Following the release of the earnings report, COYA’s price decreased to $ 3.21 on Nov 11, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 10, 2026 | -$ 0.45 | $ 3.33 | $ 3.21 | |
| Aug 11, 2026 | -$ 0.28 | $ 4.64 | $ 4.69 | |
| May 12, 2026 | -$ 0.32 | $ 4.18 | $ 4.54 | |
| Mar 16, 2026 | -$ 0.34 | $ 4.53 | $ 4.40 | |
| Nov 12, 2025 | -$ 0.10 | $ 6.01 | $ 5.96 | |
| Aug 12, 2025 | -$ 0.36 | $ 6.15 | $ 6.20 | |
| May 13, 2025 | -$ 0.44 | $ 6.14 | $ 5.69 | |
| Mar 18, 2025 | -$ 0.18 | $ 6.85 | $ 6.45 | |
| Nov 6, 2024 | -$ 0.26 | $ 6.74 | $ 7.22 | |
| Aug 12, 2024 | -$ 0.19 | $ 6.06 | $ 5.14 | |
| May 9, 2024 | -$ 0.35 | $ 8.03 | $ 8.21 | |
| Mar 19, 2024 | $ 0.15 | $ 9.86 | $ 9.96 | |
| Nov 8, 2023 | -$ 0.34 | $ 5.10 | $ 4.81 | |
| Aug 8, 2023 | -$ 0.31 | $ 3.85 | $ 3.80 | |
| May 10, 2023 | -$ 0.28 | $ 5.25 | $ 5.15 | |
| Mar 29, 2023 | -$ 0.24 | $ 3.93 | $ 3.99 | |
| Dec 30, 2022 | -$ 0.52 | $ 4.57 | $ 4.65 |
Coya Therapeutics released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Coya Therapeutics missed analysts’ expectations during the last earnings period by
